Pharmaceuticals

Asia-Pacific Recombinant Peptides Market Report 2017

  • QYR2417692
  • 104 Pages
  • January 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the Asia-Pacific Recombinant Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Recombinant Peptides for these regions, from 2012 to 2022 (forecast), including

China

Japan

South Korea

Taiwan

India

Southeast Asia

Australia

Asia-Pacific Recombinant Peptides market competition by top manufacturers/players, with Recombinant Peptides sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Sandoz Pharma

Stada Arzneimittel

Amgen

Hospira

Actavis

Cipla Ltd.

Wockhardt Ltd.

Biocon Ltd.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

Glucagon

Calcitonin

Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Oncology

Blood Disorders

Infectious Diseases

Autoimmune Diseases

Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific Recombinant Peptides Market Report 2017

1 Recombinant Peptides Overview

1.1 Product Overview and Scope of Recombinant Peptides

1.2 Classification of Recombinant Peptides by Product Category

1.2.1 Asia-Pacific Recombinant Peptides Market Size (Sales) Comparison by Types (2012-2022)

1.2.2 Asia-Pacific Recombinant Peptides Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Glucagon

1.2.4 Calcitonin

1.2.5 Other

1.3 Asia-Pacific Recombinant Peptides Market by Application/End Users

1.3.1 Asia-Pacific Recombinant Peptides Sales (Volume) and Market Share Comparison by Applications (2012-2022)

1.3.2 Oncology

1.3.3 Blood Disorders

1.3.4 Infectious Diseases

1.3.5 Autoimmune Diseases

1.3.6 Other

1.4 Asia-Pacific Recombinant Peptides Market by Region

1.4.1 Asia-Pacific Recombinant Peptides Market Size (Value) Comparison by Region (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Japan Status and Prospect (2012-2022)

1.4.4 South Korea Status and Prospect (2012-2022)

1.4.5 Taiwan Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.4.7 Southeast Asia Status and Prospect (2012-2022)

1.4.8 Australia Status and Prospect (2012-2022)

1.5 Asia-Pacific Market Size (Value and Volume) of Recombinant Peptides (2012-2022)

1.5.1 Asia-Pacific Recombinant Peptides Sales and Growth Rate (2012-2022)

1.5.2 Asia-Pacific Recombinant Peptides Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Recombinant Peptides Competition by Players/Suppliers, Region, Type and Application

2.1 Asia-Pacific Recombinant Peptides Market Competition by Players/Suppliers

2.1.1 Asia-Pacific Recombinant Peptides Sales Volume and Market Share of Key Players/Suppliers (2012-2017)

2.1.2 Asia-Pacific Recombinant Peptides Revenue and Share by Players/Suppliers (2012-2017)

2.2 Asia-Pacific Recombinant Peptides (Volume and Value) by Type

2.2.1 Asia-Pacific Recombinant Peptides Sales and Market Share by Type (2012-2017)

2.2.2 Asia-Pacific Recombinant Peptides Revenue and Market Share by Type (2012-2017)

2.3 Asia-Pacific Recombinant Peptides (Volume) by Application

2.4 Asia-Pacific Recombinant Peptides (Volume and Value) by Region

2.4.1 Asia-Pacific Recombinant Peptides Sales and Market Share by Region (2012-2017)

2.4.2 Asia-Pacific Recombinant Peptides Revenue and Market Share by Region (2012-2017)

3 China Recombinant Peptides (Volume, Value and Sales Price)

3.1 China Recombinant Peptides Sales and Value (2012-2017)

3.1.1 China Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

3.1.2 China Recombinant Peptides Revenue and Growth Rate (2012-2017)

3.1.3 China Recombinant Peptides Sales Price Trend (2012-2017)

3.2 China Recombinant Peptides Sales Volume and Market Share by Type

3.3 China Recombinant Peptides Sales Volume and Market Share by Application

4 Japan Recombinant Peptides (Volume, Value and Sales Price)

4.1 Japan Recombinant Peptides Sales and Value (2012-2017)

4.1.1 Japan Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

4.1.2 Japan Recombinant Peptides Revenue and Growth Rate (2012-2017)

4.1.3 Japan Recombinant Peptides Sales Price Trend (2012-2017)

4.2 Japan Recombinant Peptides Sales Volume and Market Share by Type

4.3 Japan Recombinant Peptides Sales Volume and Market Share by Application

5 South Korea Recombinant Peptides (Volume, Value and Sales Price)

5.1 South Korea Recombinant Peptides Sales and Value (2012-2017)

5.1.1 South Korea Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

5.1.2 South Korea Recombinant Peptides Revenue and Growth Rate (2012-2017)

5.1.3 South Korea Recombinant Peptides Sales Price Trend (2012-2017)

5.2 South Korea Recombinant Peptides Sales Volume and Market Share by Type

5.3 South Korea Recombinant Peptides Sales Volume and Market Share by Application

6 Taiwan Recombinant Peptides (Volume, Value and Sales Price)

6.1 Taiwan Recombinant Peptides Sales and Value (2012-2017)

6.1.1 Taiwan Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

6.1.2 Taiwan Recombinant Peptides Revenue and Growth Rate (2012-2017)

6.1.3 Taiwan Recombinant Peptides Sales Price Trend (2012-2017)

6.2 Taiwan Recombinant Peptides Sales Volume and Market Share by Type

6.3 Taiwan Recombinant Peptides Sales Volume and Market Share by Application

7 India Recombinant Peptides (Volume, Value and Sales Price)

7.1 India Recombinant Peptides Sales and Value (2012-2017)

7.1.1 India Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

7.1.2 India Recombinant Peptides Revenue and Growth Rate (2012-2017)

7.1.3 India Recombinant Peptides Sales Price Trend (2012-2017)

7.2 India Recombinant Peptides Sales Volume and Market Share by Type

7.3 India Recombinant Peptides Sales Volume and Market Share by Application

8 Southeast Asia Recombinant Peptides (Volume, Value and Sales Price)

8.1 Southeast Asia Recombinant Peptides Sales and Value (2012-2017)

8.1.1 Southeast Asia Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

8.1.2 Southeast Asia Recombinant Peptides Revenue and Growth Rate (2012-2017)

8.1.3 Southeast Asia Recombinant Peptides Sales Price Trend (2012-2017)

8.2 Southeast Asia Recombinant Peptides Sales Volume and Market Share by Type

8.3 Southeast Asia Recombinant Peptides Sales Volume and Market Share by Application

9 Australia Recombinant Peptides (Volume, Value and Sales Price)

9.1 Australia Recombinant Peptides Sales and Value (2012-2017)

9.1.1 Australia Recombinant Peptides Sales Volume and Growth Rate (2012-2017)

9.1.2 Australia Recombinant Peptides Revenue and Growth Rate (2012-2017)

9.1.3 Australia Recombinant Peptides Sales Price Trend (2012-2017)

9.2 Australia Recombinant Peptides Sales Volume and Market Share by Type

9.3 Australia Recombinant Peptides Sales Volume and Market Share by Application

10 Asia-Pacific Recombinant Peptides Players/Suppliers Profiles and Sales Data

10.1 Sandoz Pharma

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Recombinant Peptides Product Category, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Sandoz Pharma Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Stada Arzneimittel

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Recombinant Peptides Product Category, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Stada Arzneimittel Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Amgen

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Recombinant Peptides Product Category, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Amgen Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Hospira

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Recombinant Peptides Product Category, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Hospira Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Actavis

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Recombinant Peptides Product Category, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Actavis Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Cipla Ltd.

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Recombinant Peptides Product Category, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 Cipla Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Wockhardt Ltd.

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Recombinant Peptides Product Category, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 Wockhardt Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Biocon Ltd.

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Recombinant Peptides Product Category, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 Biocon Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

11 Recombinant Peptides Manufacturing Cost Analysis

11.1 Recombinant Peptides Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Recombinant Peptides

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Recombinant Peptides Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Recombinant Peptides Major Manufacturers in 2016

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Asia-Pacific Recombinant Peptides Market Forecast (2017-2022)

15.1 Asia-Pacific Recombinant Peptides Sales Volume, Revenue and Price Forecast (2017-2022)

15.1.1 Asia-Pacific Recombinant Peptides Sales Volume and Growth Rate Forecast (2017-2022)

15.1.2 Asia-Pacific Recombinant Peptides Revenue and Growth Rate Forecast (2017-2022)

15.1.3 Asia-Pacific Recombinant Peptides Price and Trend Forecast (2017-2022)

15.2 Asia-Pacific Recombinant Peptides Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)

15.2.1 Asia-Pacific Recombinant Peptides Sales Volume and Growth Rate Forecast by Region (2017-2022)

15.2.2 Asia-Pacific Recombinant Peptides Revenue and Growth Rate Forecast by Region (2017-2022)

15.2.3 China Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.4 Japan Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.5 South Korea Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.6 Taiwan Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.7 India Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.8 Southeast Asia Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.2.9 Australia Recombinant Peptides Sales, Revenue and Growth Rate Forecast (2017-2022)

15.3 Asia-Pacific Recombinant Peptides Sales, Revenue and Price Forecast by Type (2017-2022)

15.3.1 Asia-Pacific Recombinant Peptides Sales Forecast by Type (2017-2022)

15.3.2 Asia-Pacific Recombinant Peptides Revenue Forecast by Type (2017-2022)

15.3.3 Asia-Pacific Recombinant Peptides Price Forecast by Type (2017-2022)

15.4 Asia-Pacific Recombinant Peptides Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology/Research Approach

17.1.1 Research Programs/Design

17.1.2 Market Size Estimation

17.1.3 Market Breakdown and Data Triangulation

17.2 Data Source

17.2.1 Secondary Sources

17.2.2 Primary Sources

17.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Recombinant Peptides

Figure Asia-Pacific Recombinant Peptides Sales Volume (K MT) by Type (2012-2022)

Figure Asia-Pacific Recombinant Peptides Sales Volume Market Share by Type (Product Category) in 2016

Figure Glucagon Product Picture

Figure Calcitonin Product Picture

Figure Other Product Picture

Figure Asia-Pacific Recombinant Peptides Sales (K MT) by Application (2012-2022)

Figure Asia-Pacific Sales Market Share of Recombinant Peptides by Application in 2016

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure Blood Disorders Examples

Table Key Downstream Customer in Blood Disorders

Figure Infectious Diseases Examples

Table Key Downstream Customer in Infectious Diseases

Figure Autoimmune Diseases Examples

Table Key Downstream Customer in Autoimmune Diseases

Figure Other Examples

Table Key Downstream Customer in Other

Figure Asia-Pacific Recombinant Peptides Market Size (Million USD) by Region (2012-2022)

Figure China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure South Korea Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure Taiwan Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure Australia Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure Asia-Pacific Recombinant Peptides Sales Volume (K MT) and Growth Rate (2012-2022)

Figure Asia-Pacific Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2022)

Figure Asia-Pacific Recombinant Peptides Market Major Players Product Sales Volume (K MT)(2012-2017)

Table Asia-Pacific Recombinant Peptides Sales (K MT) of Key Players/Suppliers (2012-2017)

Table Asia-Pacific Recombinant Peptides Sales Share by Players/Suppliers (2012-2017)

Figure 2016 Asia-Pacific Recombinant Peptides Sales Share by Players/Suppliers

Figure 2017 Asia-Pacific Recombinant Peptides Sales Share by Players/Suppliers

Figure Asia-Pacific Recombinant Peptides Market Major Players Product Revenue (Million USD) 2012-2017

Table Asia-Pacific Recombinant Peptides Revenue (Million USD) by Players/Suppliers (2012-2017)

Table Asia-Pacific Recombinant Peptides Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 Asia-Pacific Recombinant Peptides Revenue Share by Players

Figure 2017 Asia-Pacific Recombinant Peptides Revenue Share by Players

Table Asia-Pacific Recombinant Peptides Sales and Market Share by Type (2012-2017)

Table Asia-Pacific Recombinant Peptides Sales Share by Type (2012-2017)

Figure Sales Market Share of Recombinant Peptides by Type (2012-2017)

Figure Asia-Pacific Recombinant Peptides Sales Growth Rate by Type (2012-2017)

Table Asia-Pacific Recombinant Peptides Revenue (Million USD) and Market Share by Type (2012-2017)

Table Asia-Pacific Recombinant Peptides Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Recombinant Peptides by Type (2012-2017)

Figure Asia-Pacific Recombinant Peptides Revenue Growth Rate by Type (2012-2017)

Table Asia-Pacific Recombinant Peptides Sales Volume (K MT) and Market Share by Region (2012-2017)

Table Asia-Pacific Recombinant Peptides Sales Share by Region (2012-2017)

Figure Sales Market Share of Recombinant Peptides by Region (2012-2017)

Figure Asia-Pacific Recombinant Peptides Sales Market Share by Region in 2016

Table Asia-Pacific Recombinant Peptides Revenue (Million USD) and Market Share by Region (2012-2017)

Table Asia-Pacific Recombinant Peptides Revenue Share (%) by Region (2012-2017)

Figure Revenue Market Share of Recombinant Peptides by Region (2012-2017)

Figure Asia-Pacific Recombinant Peptides Revenue Market Share by Region in 2016

Table Asia-Pacific Recombinant Peptides Sales Volume (K MT) and Market Share by Application (2012-2017)

Table Asia-Pacific Recombinant Peptides Sales Share (%) by Application (2012-2017)

Figure Asia-Pacific Recombinant Peptides Sales Market Share by Application (2012-2017)

Figure Asia-Pacific Recombinant Peptides Sales Market Share by Application (2012-2017)

Figure China Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure China Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure China Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table China Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table China Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure China Recombinant Peptides Sales Volume Market Share by Type in 2016

Table China Recombinant Peptides Sales Volume (K MT) by Applications (2012-2017)

Table China Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure China Recombinant Peptides Sales Volume Market Share by Application in 2016

Figure Japan Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Japan Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure Japan Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table Japan Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table Japan Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure Japan Recombinant Peptides Sales Volume Market Share by Type in 2016

Table Japan Recombinant Peptides Sales Volume (K MT) by Applications (2012-2017)

Table Japan Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure Japan Recombinant Peptides Sales Volume Market Share by Application in 2016

Figure South Korea Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure South Korea Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure South Korea Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table South Korea Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table South Korea Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure South Korea Recombinant Peptides Sales Volume Market Share by Type in 2016

Table South Korea Recombinant Peptides Sales Volume (K MT) by Applications (2012-2017)

Table South Korea Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure South Korea Recombinant Peptides Sales Volume Market Share by Application in 2016

Figure Taiwan Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Taiwan Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure Taiwan Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table Taiwan Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table Taiwan Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure Taiwan Recombinant Peptides Sales Volume Market Share by Type in 2016

Table Taiwan Recombinant Peptides Sales Volume (K MT) by Applications (2012-2017)

Table Taiwan Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure Taiwan Recombinant Peptides Sales Volume Market Share by Application in 2016

Figure India Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure India Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure India Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table India Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table India Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure India Recombinant Peptides Sales Volume Market Share by Type in 2016

Table India Recombinant Peptides Sales Volume (K MT) by Application (2012-2017)

Table India Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure India Recombinant Peptides Sales Volume Market Share by Application in 2016

Figure Southeast Asia Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Southeast Asia Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure Southeast Asia Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table Southeast Asia Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table Southeast Asia Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure Southeast Asia Recombinant Peptides Sales Volume Market Share by Type in 2016

Table Southeast Asia Recombinant Peptides Sales Volume (K MT) by Applications (2012-2017)

Table Southeast Asia Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure Southeast Asia Recombinant Peptides Sales Volume Market Share by Application in 2016

Figure Australia Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Australia Recombinant Peptides Revenue (Million USD) and Growth Rate (2012-2017)

Figure Australia Recombinant Peptides Sales Price (USD/MT) Trend (2012-2017)

Table Australia Recombinant Peptides Sales Volume (K MT) by Type (2012-2017)

Table Australia Recombinant Peptides Sales Volume Market Share by Type (2012-2017)

Figure Australia Recombinant Peptides Sales Volume Market Share by Type in 2016

Table Australia Recombinant Peptides Sales Volume (K MT) by Applications (2012-2017)

Table Australia Recombinant Peptides Sales Volume Market Share by Application (2012-2017)

Figure Australia Recombinant Peptides Sales Volume Market Share by Application in 2016

Table Sandoz Pharma Recombinant Peptides Basic Information List

Table Sandoz Pharma Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sandoz Pharma Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Sandoz Pharma Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Sandoz Pharma Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Stada Arzneimittel Recombinant Peptides Basic Information List

Table Stada Arzneimittel Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Stada Arzneimittel Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Stada Arzneimittel Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Stada Arzneimittel Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Amgen Recombinant Peptides Basic Information List

Table Amgen Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Amgen Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Amgen Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Amgen Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Hospira Recombinant Peptides Basic Information List

Table Hospira Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Hospira Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Hospira Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Hospira Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Actavis Recombinant Peptides Basic Information List

Table Actavis Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Actavis Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Actavis Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Actavis Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Cipla Ltd. Recombinant Peptides Basic Information List

Table Cipla Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Cipla Ltd. Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Cipla Ltd. Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Cipla Ltd. Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Wockhardt Ltd. Recombinant Peptides Basic Information List

Table Wockhardt Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Wockhardt Ltd. Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Wockhardt Ltd. Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Wockhardt Ltd. Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Biocon Ltd. Recombinant Peptides Basic Information List

Table Biocon Ltd. Recombinant Peptides Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Biocon Ltd. Recombinant Peptides Sales (K MT) and Growth Rate (2012-2017)

Figure Biocon Ltd. Recombinant Peptides Sales Market Share in Asia-Pacific (2012-2017)

Figure Biocon Ltd. Recombinant Peptides Revenue Market Share in Asia-Pacific (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price (USD/MT) Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Peptides

Figure Manufacturing Process Analysis of Recombinant Peptides

Figure Recombinant Peptides Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Peptides Major Manufacturers in 2016

Table Major Buyers of Recombinant Peptides

Table Distributors/Traders List

Figure Asia-Pacific Recombinant Peptides Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure Asia-Pacific Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Asia-Pacific Recombinant Peptides Price (USD/MT) and Trend Forecast (2017-2022)

Table Asia-Pacific Recombinant Peptides Sales Volume (K MT) Forecast by Region (2017-2022)

Figure Asia-Pacific Recombinant Peptides Sales Volume Market Share Forecast by Region (2017-2022)

Figure Asia-Pacific Recombinant Peptides Sales Volume Market Share Forecast by Region in 2022

Table Asia-Pacific Recombinant Peptides Revenue (Million USD) Forecast by Region (2017-2022)

Figure Asia-Pacific Recombinant Peptides Revenue Market Share Forecast by Region (2017-2022)

Figure Asia-Pacific Recombinant Peptides Revenue Market Share Forecast by Region in 2022

Figure China Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure China Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Japan Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Japan Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure South Korea Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure South Korea Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Taiwan Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Taiwan Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure India Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure India Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Australia Recombinant Peptides Sales (K MT) and Growth Rate Forecast (2017-2022)

Figure Australia Recombinant Peptides Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Asia-Pacific Recombinant Peptides Sales (K MT) Forecast by Type (2017-2022)

Figure Asia-Pacific Recombinant Peptides Sales Market Share Forecast by Type (2017-2022)

Table Asia-Pacific Recombinant Peptides Revenue (Million USD) Forecast by Type (2017-2022)

Figure Asia-Pacific Recombinant Peptides Revenue Market Share Forecast by Type (2017-2022)

Table Asia-Pacific Recombinant Peptides Price (USD/MT) Forecast by Type (2017-2022)

Table Asia-Pacific Recombinant Peptides Sales (K MT) Forecast by Application (2017-2022)

Figure Asia-Pacific Recombinant Peptides Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370